GNS Corporate is the partner of multinational companies in Turkey especially working in the field of rare diseases and gene therapy.
New virtual screening strategy identifies existing drug that inhibits Covid-19 virus
In lab experiments, pralatrexate outperforms remdesivir against SARS-CoV-2